Getting your blood drawn is never a fun experience, and some people are better about it than others. There are the ones who can sit still and not make a peep, and those who hyperventilate, cry, faint at the sight of blood. Then there are those who have real medical conditions, like requiring butterfly needles for smaller veins or gentler pressure to avoid bruising.
A Mountain View, CA-based startup is trying to make that process more at ease. With the Veebot, this medical robot technician can scan the patient’s arm using an image-analysis software to select the vein that’s ideal for drawing blood. The patient would first insert his or her arm through a padded archway where an inflatable cuff pumps the arm to restrict blood flow. Then, Veebot will use ultrasound and infrared light to examine the best vein before aligning the needle and inserting it through. There’s even a grip for the patient to hold to help pump blood (or squeeze for nervousness). The team estimates that Veebot only takes one minute to process all this information – the only thing the human nurse has to do is attach the blood test tube and, of course, supervise the patient in case they pass out.
At the moment, Veebot has an 83 percent accuracy at selecting the best vein, which is more than some of us can say about nurses who poke and prod multiple times before they find a useable spot. The team is currently working on upping that rate to 90 percent accuracy before starting clinical trials. Veebot’s Richard Harris, a third-year undergraduate in Princeton University’s mechanical engineering program, tells IEEE Spectrum that the idea started because it combined his love for both robotics and computer vision. “It had demanding requirements because you’d be fully automating something that is different every time and deals with humans,” he explained. Such complexities did not come without obstacles; the original prototypes for Veebot date all the way back to 2009.
Now that a successful version is nearly ready, Harris is gearing up to sell to large medical facilities with an estimated market of $9 million. But before you shy away thinking this robot will probably try to kill you while you’re not looking, look at it this way: Surgical robots have existed for years and are pretty common in most hospitals these days. A blood test is much less complex than surgery, so the process can’t be that bad… right? Besides, if you don’t like Veebot, there are plenty of other robots that can help you draw some blood – and it ain’t gonna be pretty.
Related Posts
Your WhatsApp voice notes could help screen for early signs of depression
The study, led by researchers in Brazil including Victor H. O. Otani from the Santa Casa de São Paulo School of Medical Sciences, found that their AI could identify depression in female participants with 91.9% accuracy. All the AI needed was a simple recording of the person describing how their week went.
Talk to AI every day? New research says it might signal depression
This finding comes from a national survey of nearly 21,000 U.S. adults conducted in 2025, where participants detailed how often they interacted with generative AI tools and completed standard mental health questionnaires. Within that group, about 10% said they used AI daily, and 5% said they engaged with chatbots multiple times throughout the day. Those daily users showed higher rates of reported depressive symptoms and other negative emotional effects, such as anxiety and irritability.
You might actually be able to buy a Tesla robot in 2027
The comments follow a series of years-long development milestones. Optimus, which was originally unveiled as the Tesla Bot in 2021, has undergone multiple prototype iterations and has already been pressed into service handling simple tasks in Tesla factories. According to Musk, those internal deployments will expand in complexity later this year, helping prepare the robotics platform for broader use.